FDA Clearance Tracker · K161324
Raycell Mk2
Last checked: Nov 20, 2026Latest source record: Aug 12, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Aug 12, 2016
Substantially Equivalent
Time to decision
93 days
Received May 11, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Unclassified
The decision
- FDA number
- K161324
- Device name
- Raycell Mk2
- Applicant
- Best Theratronics Limited
- Applicant location
- Ottawa, CA
- Received
- May 11, 2016
- Decided
- Aug 12, 2016
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Unclassified
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MOT. The earliest in FDA's data is K837346, decided Jun 24, 1983.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K161324
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Best Theratronics Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Raycell MK1510(k)
K181737 · Decided Jan 2, 2019 · 184 days after receipt
Device type: Irradiator, Blood To Prevent Graft Versus Host Disease (MOT) · Radiology & Imaging
- GammaBeam 500510(k)
K150191 · Decided Apr 17, 2015 · 79 days after receipt
Device type: System, Radiation Therapy, Radionuclide (IWB) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.